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Previous studies in adults with dilated cardiomyopathy suggest 
that the presence of arrhythmia, especially ventricular tachycar-
dia, correlates with increased mortality. We performed a retro-
spective analysis of 63 children with idiopathic dilated cardiomy-
opathy to determine the prognostic significance of arrhythmias 
and other findings with respect to mortality. 
The mean age at diagnosis of the cardiomyopathy was 4.96 ± 
5.3 years. The overall mortality rate was 16% over a 10 year 
follow-up period. Persistent congestive heart failure and ST-T 
wave changes correlated with increased mortality (p < 0.05). No 
other variables affected outcome. 
In contrast to children, the prognostic significance of ar-
rhythmias in adults with idiopathic dilated cardiomyopathy 
has been studied extensively (1-17). In adults, sudden death 
has been related to the presence of arrhythmias, but whether 
pharmacologic control of these arrhythmias significantly 
alters outcome is controversial. Children with idiopathic 
dilated cardiomyopathy also have arrhythmias. However, it 
has not been demonstrated whether the control of these 
arrhythmias alters outcome. The goals of this study were to 
discover if any laboratory or clinical findings or evidence of 
arrhythmias was useful in predicting outcome for children 
with idiopathic congestive cardiomyopathy and whether 
antiarrhythmic therapy favorably affected outcome. 
Methods 
Patient selection. Clinical records of patients diagnosed 
with idiopathic dilated congestive cardiomyopathy at Texas 
Children's Hospital were reviewed. Patients with any hemo-
dynamically significant congenital heart defect, previous 
history of therapy with any antineoplastic agent or an inborn 
error of metabolism with potential for myocardial involve-
ment were excluded from the study. None of the patients 
were considered to have cardiomyopathy as a result of a 
primary arrhythmia. 
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Arrhythmias were found in 46% of the patients; of the 
arrhythmias, 48% were atrial arrhythmias. Ventricular tachycar-
dia was present in six patients. Death occurred in 4 (14 %) of 29 
patients with known arrhythmia; 1 of the 5 died suddenly. The 
remaining 6 deaths in the series occurred in the 34 patients 
without a documented arrhythmia. 
It is concluded that 1) arrhythmias are frequently seen in 
children with dilated cardiomyopathy but are not predictive of 
outcome; 2) sudden death in children with this disease is rare; and 
3) persistent congestive heart failure portends a poor prognosis. 
(J Am Coil CardioI1991;18:152-6) 
Patient profile. Sixty-three patients were identified and 
their data analyzed. There were 35 boys (55%) and 28 girls 
(45%). The mean age at diagnosis ± SD was 4.96 ± 5.3 
years, mean duration of illness from diagnosis was 4.72 ± 4.6 
years and mean follow-up was 4.0 ± 4.0 years. In 61 of the 
63 patients, dilated cardiomyopathy was an isolated finding; 
two patients had a small secundum atrial septal defect that 
was hemodynamically insignificant. 
Clinical and laboratory data analysis. The following infor-
mation was obtained: gender, age at diagnosis and last 
follow-up visit, duration of illness (presentation to last 
follow-up), signs and symptoms of congestive heart failure 
and palpitation, history of viral syndrome within 8 weeks of 
presentation and outcome. Type and efficacy of initial drug 
therapy and therapy at the last follow-up visit were assessed. 
Laboratory evaluation included examination of the 15 
lead electrocardiogram (ECG) for rhythm disturbance, heart 
rate, PR segment, QRS duration, QT interval (corrected by 
the Bazett formula) (18), P wave and QRS axis in the frontal 
plane, ST or T wave changes, or both, in the chest or limb 
leads «1 mm ST segment depression, flattened or inverted 
T waves). The chest radiograph in the posteroanterior pro-
jection was assessed and graded as follows: normal =: 
cardiac size <50% of the cardiothoracic ratio; mild cardio-
megaly = 60% of the cardiothoracic ratio; moderate to 
severe cardiomegaly = >60% of the cardiothoracic ratio. 
Echocardiographic data were reviewed. Before 1977, 
patients had M-mode assessment only; those evaluated later 
had both M -mode and two-dimensional echocardiography. 
Left atrial, left ventricular and right ventricular enlargement 
were assessed by two-dimensional measurements; shorten-
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ing fraction (in %) was calculated as previously described 
(19) and compared with normal published values. 
Cardiac arrhythmias. Twenty-four hour ambulatory 
EeG (Holter) monitoring reports were reviewed and avail-
able tracings were analyzed for arrhythmias. Premature 
atrial, junctional and ventricular complexes were defined as 
frequent when> 30th. Patients were included in the arrhyth-
mia category if an arrhythmia was detected with anyone of 
the following methods: standard 15 lead EeG, ambulatory 
EeG monitor, exercise testing or electrophysiologic testing 
performed during cardiac catheterization. 
Patients with an arrhythmia were classified into four 
groups: arrhythmia controlled and patient living; arrhythmia 
controlled but patient dead; arrhythmia partially controlled 
and patient living; and arrhythmia partially controlled but 
patient dead. We defined control of arrhythmia as an ab-
sence at follow-up of a previously documented arrhythmia, 
or, in the case of extrasystoles, as a decrease to <30th. 
Exercise testing and cardiac catheterization. Exercise 
testing was performed using a modified Bruce protocol with 
continuous EeG monitoring. Development of an arrhythmia 
during or after the exercise period was recorded and those 
patients were assigned to one of the four arrhythmia groups. 
Hemodynamic and electrophysiologic catheterization data 
were assessed at the earliest time after presentation and at 
the time of the last follow-up (if serial studies were per-
formed). 
Statistical analysis. Electrocardiographic intervals and 
echocardiographically determined shortening fraction at pre-
sentation and follow-up were analyzed with Student's t test. 
A chi-square test was used to assess outcome in relation to 
specific laboratory or physical findings. A Fisher's exact test 
with use of the Yates correction was applied when a group 
had fewer than five patients. An odds ratio (relative risk) was 
determined for estimating the clinical utility of a particular 
finding and outcome as follows: incidence of death in a group 
with ( + ) a particular finding versus the incidence of death in 
a group without (-) the finding (20). A one-way variance 
analysis was performed on each variable to assess whether 
the presence or absence of a finding was correlated with 
death as an outcome. 
Results 
Symptoms at presentation. A history of a viral syndrome 
within 8 weeks of presentation was found in 16 (25%) of the 
63 patients; the remainder reported no recent infectious 
illness. One or more symptoms occurred in 42 patients (66%) 
at the time of presentation. The most common were short-
ness of breath, dyspnea on exertion or paroxysmal nocturnal 
dyspnea and peripheral edema suggesting congestive heart 
failure. Palpitation occurred in 9 (14%) of 63 patients; 
syncope or near syncope was reported in 8 (13%). 
Electrocardiographic findings (Table 1). Analysis of the 
15 lead EeG disclosed no significant differences between 
results at presentation and at follow-up except for right atrial 
FRIEDMAN ET AL. 153 
DILATED CARDIOMYOPATHY IN CHILDREN 
Table 1. Electrocardiographic Data (15 leads) At Presentation in 
63 Patients 
Presentation 
Surface EeG Follow-Up p Value 
Axis P wave 55.3 ± 18.9 50 ± 20 NS 
Axis QRS complex 70.2 ± 47.2 71±48 NS 
RAE 14/58 (24%) 7/50 (14%) <0.05 
RVH 11159 (19%) 6/50 (12%) <0.05 
LAE 15/59 (25%) 11150 (22%) NS 
LVH 26/58 (45%) 14/50 (28%) <0.05 
SCL (ms) 644 ± 234 715 ± 161 NS 
PR (ms) 136.5 ± 30.6 151 ± 44 NS 
QRS duration (ms) 72.5 ± 26.1 80 ± 21.6 NS 
QTc (ms) 0.43 ± 0.04 0.44 ± 0.05 NS 
ST-Twave 27/57 (47%) 18/50 (36%) <0.05 
Values are ± 1 SD. LAE = left atrial enlargement; LVH = left ventricular 
hypertrophy; PR = PR interval; QTc = QT interval corrected for heart rate; 
RAE = right atrial enlargement; RVH = right ventricular hypertrophy; SCL 
= sinus cycle length. 
enlargement, right ventricular hypertrophy, left ventricular 
hypertrophy, and ST or T wave changes, or both, all of 
which were less common at follow-up (p < 0.05). 
Chest radiography and echocardiography at presentation 
and follow-up. A review of chest radiographs showed that 
although overall grading tended to improve from presenta-
tion to follow-up, no statistically significant differences ex-
isted between the two groups. Likewise, echocardiographic 
findings of a dilated right ventricle or enlarged left atrium 
were common though there was no significant difference in 
the number of patients with these findings between presen-
tation and follow-up. Percent shortening fraction was de-
pressed in both groups but significantly improved at the time 
offollow-up (24 ± 9.7% vs. 29 ± 11.7%, p < 0.05). Only five 
patients underwent serial cardiac catheterization; thus no 
statistical analysis could be performed to evaluate the 
changes from presentation to follow-up. 
Cardiac arrhythmias (Table 2). Electrocardiograms were 
available for comparison at presentation and follow-up in 53 
(85%) of the 63 patients. Holter EeG monitoring was per-
formed in 22 patients at presentation and again at follow-up 
in 20 patients (90%). The time between presentation and 
follow-up was 2:6 months in all patients. Of the 63 patients, 
an arrhythmia was found during illness in 29 (46%). Among 
these 29 patients, atrial arrhythmias were more common 
than ventricular arrhythmias (48% vs. 34%, p < 0.05). 
Supraventricular arrhythmias were seen in 14 patients; ven-
tricular arrhythmias were seen in 10 patients; both types 
were seen in 5 patients. Atrial fibrillation and atrial flutter 
were common, each occurring in five patients. Of the 15 
patients in whom ventricular arrhythmias were present, 6 
(40%) had ventricular tachycardia. 
Outcome and survival (Fig. 1). The average time from 
diagnosis until death in those who died from their illness was 
3 years. However, 9 of the 10 patients who died did so within 
2.5 years of diagnosis. The overall mortality rate was 16% 
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Table 2. Arrhythmia Profile in 29 Patients With 
Documented Arrhythmia 
Location and Type 
Atrial (14) 
AFib/AFI 
SVT 
SSS 
Freq PAC 
Ventricular (10) 
VT 
Freq PVC's 
Couplets 
Both (5) 
Freq PVCIPAC 
Freq PVC/SVT 
Freq PVC/wPW/SVT 
SSSNT 
Freq PVC/AET 
No. of Patients 
(10) 
(I) 
(2) 
(I) 
(6) 
(3) 
(I) 
(1) 
(I) 
(1) 
(I) 
(1) 
Values in parentheses are number of patients. AET = atrial ectopic 
tachycardia; AFib/AFI = atrial fibrillation and/or flutter; Freq = frequent; 
PAC = premature atrial complexes; PVC = premature ventricular complexes; 
SSS = sick sinus syndrome; SVT = supraventricular tachycardia; VT = 
ventricular tachycardia; WPW = Wolff-Parkinson-White syndrome. 
(10 patients); however, patients who continued to have 
symptoms of congestive heart failure despite therapy had a 
significantly higher mortality rate than those who were not in 
failure at the time offollow-up (41% vs. 5%, p < 0.05). Those 
patients who presented at baseline and at follow-up with ST 
or T wave changes, or both, on their ECG also demonstrated 
a higher mortality rate (p < 0.05). Neither gender, age at 
presentation nor duration of illness was a significant deter-
minant of outcome in this study. No other clinical or 
laboratory finding was statistically correlated with poor 
outcome. 
In order to clarify the possible clinical utility of these 
findings, relative risks for mortality were determined for 
each variable. When congestive heart failure persisted de-
spite therapy, there was an 11. 7: 1 odds ratio for death (7 
Figure 1. A 10 year survival analysis curve for 63 children with 
idiopathic dilated cardiomyopathy. The cumulative survival rate is 
84%; the majority of patients died within the first few years after 
diagnosis. 
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[39%] of 18 patients with congestive heart failure at fol-
low-up died vs. 2 [5%] of 39 without failure). Likewise, if ST 
or T wave changes, or both, persisted at follow-up, the odds 
ratio for death was 16.6:1 (33% vs. 3%). A lower, but still 
significant, odds ratio of 5.3:1 favoring a poor outcome was 
found in patients who demonstrated left atrial enlargement 
on the surface ECG at follow-up. However, the presence or 
absence of any type of arrhythmia was not predictive of 
death, having an odds ratio of only 1.1:1. 
Arrhythmia and outcome. Of the 29 patients identified 
with an arrhythmia, 5 (17%) died, 1 of whom died suddenly. 
An additional 5 patients (15%) died among the 34 patients 
with no arrhythmia. Two of the deaths in the latter group 
were sudden; the other three patients died with refractory 
congestive heart failure. None of these five patients had an 
arrhythmia identified on routine ECG; however, none of 
them had a 24-h Holter ambulatory ECG monitor or electro-
physiologic study performed. Therefore, the two sudden 
deaths could have been arrhythmic in nature. 
To ascertain the effect of pharmacologic control of an 
arrhythmia, we classified the 29 patients with arrhythmia 
into four groups: arrhythmia controlled and patient living; 
arrhythmia controlled but patient dead; arrhythmia partially 
controlled and patient living; and arrhythmia partially con-
trolled but patient dead. More than half (55%) of the 29 
patients had control of their arrhythmia and were living; no 
patient whose arrhythmia was controlled died. Of the 13 
patients with partially controlled arrhythmia 5 (38%) died, 
including 1 who died suddenly. Although the number of 
patients was small, among patients with a documented 
arrhythmia, three of four with a supraventricular arrhythmia 
had atrial fibrillation or flutter that was only partially con-
trolled by our criteria. No patient with atrial fibrillation or 
flutter that was successfully controlled with medication died. 
One patient with a poorly controlled ventricular arrhyth-
mia died. He had ventricular tachycardia and had sudden 
cardiac arrest during monitoring. The terminal arrhythmia 
began with a short run of ventricular tachycardia that 
quickly degenerated into ventricular fibrillation. In the other 
two cases of sudden death, neither 24-h ambulatory ECG 
monitoring nor electrophysiologic study was performed; 
therefore, whether and what type of arrhythmias existed 
could not be ascertained. 
Discussion 
Unlike previous studies in children (21-24) and most 
studies in adults, the present investigation revealed a high 
frequency of supraventricular arrhythmias in our patients 
with idiopathic dilated cardiomyopathy. The presence of 
atrial fibrillation or flutter, when poorly controlled, may be 
associated with a high mortality. 
Previous studies in children. There are few studies of 
children with idiopathic dilated cardiomyopathy. Taliercio et 
al. (21) reviewed 24 patients <20 years of age who had 
idiopathic dilated cardiomyopathy. The majority presented 
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with congestive heart failure and only one patient had a 
ventricular arrhythmia. Six patients (25%) developed com-
plex premature ventricular ectopic activity during follow-up. 
Ventricular tachycardia was demonstrated in four patients 
who underwent electrophysiologic study (three with sus-
tained and one with nonsustained ventricular tachycardia). 
In their study one sudden death was reported, presumably 
due to a ventricular arrhythmia. The majority of the deaths 
were attributed to "pump failure." 
Another study (24) in infants and children with dilated 
cardiomyopathy found that persistent cardiomegaly and the 
development of arrhythmias detected on ambulatory ECG 
monitoring were significant risk factors for poor outcome. 
Complex ventricular arrhythmias were much more promi-
nent than were atrial arrhythmias in the patients with a poor 
outcome. Griffin et al. (24) concluded that the appearance of 
atrial fibrillation or flutter, or both, or complex ventricular 
ectopic activity could be a marker of myocardial dysfunction 
in a dying patient. Greenwood et al. (23) reviewed 16 
children with primary myocardial disease and found that 
ventricular arrhythmias were more common than atrial ar-
rhythmias. In that study the presence or type of arrhythmia 
did not seem to alter outcome. Harris et al. (22) studied eight 
children with cardiomyopathy. None of their patients had a 
documented arrhythmia, although only one patient had a 
24-h ambulatory ECG monitor performed. In that study, one 
patient died suddenly and another two patients died of 
congestive heart failure. 
Previous studies in adults. Studies in adult patients have 
mostly addressed the prognostic implications of ventricular 
arrhythmias and refractory congestive heart failure (1-8,10, 
13,15,25). Several investigators (8,13,14,25) found that the 
presence of ventricular tachycardia or complex ventricular 
arrhythmia, or both, were independent predictors of sudden 
and non sudden death, while others have failed to confirm 
this relation (1,2,6,7,10). Furthermore, it is controversial 
whether electrophysiologic testing and a favorable response 
to antiarrhythmic therapy help to predict outcome 
(4,12,15,17). 
The importance of atrial arrhythmia in the adult patient 
with dilated cardiomyopathy has not been clearly defined, 
although some investigators have documented atrial fibrilla-
tion or flutter in up to 50% of patients. In a study (8) of 69 
adults with nonischemic dilated cardiomyopathy, the pres-
ence of atrial fibrillation or flutter ranked significantly lower 
in importance than did ventricular arrhythmias in determin-
ing mortality. 
Clinical implications. Despite the inherent difficulties in 
the design of a retrospective analysis, we believe that certain 
conclusions that have not been previously stressed can be 
drawn from our study: 1) sudden death is uncommon in 
children with idiopathic dilated cardiomyopathy; 2) persist-
ent congestive heart failure appears to be correlated with a 
poor outcome; 3) atrial arrhythmias are more frequent than 
ventricular arrhythmias in these patients; and 4) the pres-
ence of atrial fibrillation or flutter, if poorly controlled, may 
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be related to death. Attempts to control atrial fibrillation or 
flutter with standard as well as newer antiarrhythmic agents 
is justified. We agree with Griffin et al. (24) that atrial flutter 
may serve as a marker for a severely compromised myocar-
dium; that is, these arrhythmias may be a manifestation of 
heart failure. Given the extent of the underlying myocardial 
dysfunction, atrial flutter may result in an unstable hemody-
namic state and precipitate death. 
Though one of our patients with poorly controlled ven-
tricular tachycardia died suddenly, the presence of ventric-
ular arrhythmias did not statistically correlate with predic-
tion of sudden death. It is possible that the other sudden 
deaths were due either to occult ventricular arrhythmias or 
to the development of atrial fibrillation or flutter and the 
resultant unstable state. We therefore recommend the use of 
routine ambulatory ECG monitoring in all children with 
idiopathic dilated cardiomyopathy to attempt to find arrhyth-
mias that might respond to appropriate therapy. Further 
study concerning the prognostic significance of arrhythmias 
and their control in this patient group is justified. 
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